470 - Randomized Placebo-Controlled Trial of Difluoromethylornithine (DFMO) Plus Aspirin for the Prevention of Colorectal Adenoma Recurrence and Reduction in Aberrant Crypt Foci (ACF) in Patients with Prior Advanced Adenomas or Cancer